Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia

Objective. To evaluate safety and efficacy of intravenous ferric carboxymaltose (FCM) versus standard medical care (SMC) for iron-deficiency anemia (IDA) in postpartum women and women with heavy menstrual bleeding. Study Design. This open-label, multicenter study randomized women with IDA (hemoglobi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Anemia
Autors principals: Seid, Melvin H., Butcher, Angelia D., Chatwani, Ashwin
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5406716/
https://ncbi.nlm.nih.gov/pubmed/28487769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/9642027
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars